ICL - Mergers and acquisitions

Delivers annual sales of $7,536 million, with adjusted EBITDA of $1,754 million, and continued strong cash generation of $818 million ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Consolidated annual sales were $7,536 million versus a record $10,015 million in 2022. Net income was $647 million versus $2,159 million, while adjusted net income was $715 million versus $2,350 million. Annual adjusted EBITDA was $1,754 million versus $4,007 million in 2022. Diluted earnings per share for 2023 were $0.50, while adjusted diluted EPS was $0.55. Operating cash flow was $1,5

Issues 2022 guidance with focus on strategic specialties ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter ended December 31, 2021. Consolidated sales of $2,038 million were up 55% year-over-year versus $1,317 million. Operating income of $461 million was up 232%, while adjusted operating income of $458 million was up 220%. Net income of $283 million was up 335%, while adjusted net income of $339 million was up nearly 400%. Adjusted EBITDA of $575 million was up 115% over $268 million. For the full year, consolidated sales of $6,955 million were up 38% year-over-year versus $5,043 million. Operating income

Record results in Industrial Products, Phosphate Solutions and Innovative Ag Solutions, aided by continued focus on specialties ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2021. Consolidated sales of $1,617 million were up 34% year-over-year. Operating income of $243 million was up versus an operating loss of $169 million, while adjusted operating income of $236 million was up 84% versus $128 million. Net income of $140 million was up versus a net loss of $168 million, while adjusted net income of $135 million was up nearly 90% versus $72 million. Adjusted EBITDA of $351 million was up 4

Acquisition positions ICL as Brazil's leading specialty plant nutrition company ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals and specialty chemicals company, today announced it has completed the acquisition of Compass Minerals América do Sul S.A., which includes the South American Plant Nutrition business of Compass Minerals, for approximately US$420 million. The South American Plant Nutrition business is the leading specialty plant nutrition business in Brazil and offers a broad range of solutions for plant nutrition and stimulation, covering all key Brazilian crops. Its product portfolio includes enhanced efficiency fertilizers and controlled-release fertilizers, soil

TEL AVIV, Israel, Feb. 11, 2021 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals and specialty chemicals company, today reported its financial results for the fourth quarter and full year ended December 31, 2020. Consolidated fourth quarter sales of $1.3 billion were up more than $200 million year-over-year. Net income of $65 million was up 35%, and adjusted EBITDA of $268 million in the fourth quarter was up more than 30% year-over-year. Operating income of $139 million was up nearly 60% over the fourth quarter of last year, and all four divisions delivered year-over-year improvement in both sales and operating income in the quarter. Adjusted operating inc